Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$22.08 - $47.08 $386,399 - $823,900
-17,500 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$22.67 - $35.0 $1.66 Million - $2.56 Million
-73,100 Reduced 80.68%
17,500 $486,000
Q1 2019

May 15, 2019

BUY
$26.93 - $34.7 $2.44 Million - $3.14 Million
90,600 New
90,600 $3.01 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.3B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.